USNA USANA Health Sciences, Inc. Common Stock

NYSE · Consumer products · SEC EDGAR에서 보기 ↗
$13.59
가격 · 8월 19, 2026
기준 재무 정보 8월 13, 2026

USANA Health Sciences, Inc. Common Stock 정보 위키백과 회사 개요

USANA Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, USANA was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 25 countries via a network of independent distributors.

더 보기

USANA Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, USANA was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 25 countries via a network of independent distributors.

History

In 1992, immunologist and microbiologist Myron Wentz moved his diagnostic testing company, Gull Laboratories, from Salt Lake City to West Valley City, Utah, and spun it into USANA Health Services, a multilevel marketing manufacturer of supplements. Beginning in 1993, Dallin A. Larsen served as USANA's vice president of sales (and later as a consultant to USANA's president and special advisor to the board of directors) before founding the MLM beverage company Monavie in 2005. USANA's products are not available through retail channels, and can only be obtained through one of its independent distributors (referred to as "associates") or by direct order through the company.

On 20 February 2007, Barry Minkow, founder of the Fraud Discovery Institute, distributed a 500-page report to officials at the U.S. Securities and Exchange Commission (SEC), the Federal Bureau of Investigation (FBI), and the Internal Revenue Service (IRS) accusing USANA of operating an illegal pyramid scheme. The SEC conducted an investigation into USANA's business practices in March 2007 and found no evidence of wrongdoing, concluding its inquiry with no enforcement action recommended. Minkow acknowledged that he was shorting USANA's shares, hoping to profit from a drop in the stock price. In April 2007, a class action lawsuit was filed alleging that USANA's common stock had been artificially inflated. In August 2007, USANA was notified by the Securities and Exchange Commission (SEC) that its shares were subject to delisting from the NASDAQ due to its Form 10-Q, and was determined to be in compliance that October.

In January 2008, a shareholder suit was filed with allegations that USANA had misled investors about the sustainability of its growth and business model. The cases were dismissed, and the company was cleared by the U.S. Securities and Exchange Commission after an informal inquiry into the allegations, stating that it did "not intend to recommend any enforcement action by the Commission." Later that year, two Canadian USANA distributors were awarded $7 million in damages for their wrongful dismissal from the company. The firm had terminated their positions in 2003 because it believed the distributor had violated the companies' policies and procedures.

USANA filed suits against Minkow and his company claiming defamation and stock manipulation. USANA dropped the defamation suit and in March 2008 U.S. District Judge Tena Campbell threw out four of the five claims brought by USANA against Minkow ruling that USANA's claims violated California's anti-SLAPP law for suing Minkow for fair criticism and that USANA did not show a reasonable probability of winning on those claims. The remaining charge of stock manipulation was settled in July 2008, when USANA and Minkow reached an undisclosed settlement that included the removal of all USANA-related materials from the Fraud Discovery Institute website, a related Chinese website, and YouTube. Minkow also agreed to never trade in USANA's stock again.

In December 2010, USANA completed the application process to transfer its common stock listing from the NASDAQ National Market System, where it had traded since 1996, to the New York Stock Exchange. The transfer became official at the beginning of 2011. It received drug-establishment registration from the Food and Drug Administration to manufacture over-the-counter drugs later that year. In 2012, 91% of product sales were purchased by associates. The company acquired BabyCare Ltd., a China-based prenatal supplement company, in 2013 and announced plans to build a manufacturing facility in the country.

By 2018, USANA had reported record revenue due to growth in the Asia-Pacific region, though it recorded a 7% drop in net sales during its 2019 annual report. USANA has partnered with HealthCorps on health education for children and, in 2019, the USANA Foundation's Kids Eat program opened a facility to pack and distribute food for childhood hunger in the Utah area. It was also announced as the official nutritional partner of the Spartan Race endurance brand in the United States. Its sales for the first quarter of 2020 declined by 2.3 percent compared with 2019 numbers.

In February 2019, the Ministry of Commerce in China suspended operations of all multi-level marketing companies and participants to conduct a 100-day review of the country's health foods industry due to exaggerated advertising claims and questionable products in the unregulated sector. Chinese departments initiated "Hundred Days of Action" to clean up the health market, where 49 products from various companies were revoked, 54 food business licenses of various companies were revoked, 90 business licenses of various companies were revoked, and 465 counterfeit and fake dens were destroyed. 85 companies, including BabyCare Ltd., a USANA subsidiary, signed a declaration to self-discipline and regulate operations, with BabyCare speaking at an event hosted by the Chinese government.

Corporate affairs

Leadership

In 2007, USANA faced repeated controversy after members of its board of directors, medical advisory board and several of its executives made false statements regarding their qualifications, including education and licenses.

Founder Myron Wentz was the company's chief executive officer from 1992 until 2008, when his son, Dave Wentz, succeeded him after working in positions such as president, executive vice president, and senior vice president of strategic development. In 2015, USANA announced that the chief executive officer role would be divided between Wentz and Kevin Guest, with the former taking global operations and the latter, field development and sales. Guest was appointed the sole chief executive officer in November 2016.

Operations

USANA, a multilevel marketing company, sells its products primarily through non-employee distributors, known as sales "associates", as well as through the Internet. The firm's 2010 income disclosure statement defines "associates" as those who are actively building a business, acting as wholesale buyers, or are new distributors. The firm's 2009 SEC 10-K filing distinguishes between associates and preferred customers. Associates are independent distributors of USANA products and also purchase them for personal use. Preferred customers may purchase products at wholesale prices strictly for personal use and are not permitted to resell or distribute them. As of July 2011, the firm had 222,000 active Associates and 68,000 preferred customers. It manufactured 90% of its products at the Salt Lake City headquarters, which produced more than 22 million tablets each week.

Associates may be eligible to receive commissions based on their own product sales as well as through sales made by any new distributors they recruit. According to documentation from USANA corporate, 87 percent of associates fail to make enough from commissions to recover the cost of their qualifying purchases with 67 percent of all associates making no commission; the top 2.31 percent of associates earns 72.2 percent of the company's commissions. According to a 2011 article published by the Salt Lake City Tribune, the firm's FY09 income disclosure statement indicated that the average yearly income of the company's 165,710 associates, which includes those just starting, was $617, while the "top-of-the-pyramid distributors earn an average of $857,865 annually".

Sponsorships

USANA has been a paid sponsor of various athletic organizations. USANA offers an "Athlete Guarantee Program" to select sponsored athletes. The program permits selected participants to enter into an agreement with the company stipulating that, should an athlete enrolled in the program test positive for a banned substance (included in World Anti-Doping Agency regulations) as a result of taking USANA products, the company will compensate the athlete up to two times his or her current annual earnings up to $1 million USD.

In 2006, USANA signed a co-sponsorship agreement with the WTA Tour and extended it in 2011. The agreement provides athletes with nutritional supplements that are guaranteed to conform to the Tour's antidoping policy. As part of the agreement in 2011, USANA donated $1 to Children's Hunger Fund for every ace scored at a WTA tournament beginning at Wimbledon and continuing through the end of the season.

In 2003, USANA became the title sponsor of the USANA Amphitheatre, an outdoor amphitheatre based in West Valley City, Utah with a seating capacity of 20,000. In May 2012, United Concerts announced a continued naming rights partnership with USANA Health Sciences through March 2018.

In the lead-up to the 2020 Summer Olympics, USANA announced partnerships with USA Swimming and the USA Skateboarding National Team. It was the official multivitamin sponsor of USA Swimming and official nutritional supplement supplier of USA Skateboarding. The partnerships reportedly extended into multi-year agreements.

Products

USANA produces three product lines: USANA Nutritionals (Cellsentials, Optimizers, and Digestion/Detox nutritional supplements), USANA Diet & Energy (Reset meal replacement shakes, protein bars, and Rev3 energy drinks), and Sensé & Celavive personal care (skin care, skin treatment, and hair & body care products).

USANA Essentials were tested in 2011 by ConsumerLab.com in its Multivitamin and Multimineral Supplements Review of 38 leading multivitamin/multimineral products sold in the U.S. and Canada. The Essentials passed ConsumerLab's test, which included testing of selected index elements, their ability to disintegrate in solution per United States Pharmacopeia guidelines, lead contamination threshold set in California Proposition 65, and meeting U.S. Food and Drug Administration (FDA) labeling requirements.

As of 2019, its products are marketed in the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, the United Kingdom, the Caribbean, Puerto Rico, Philippines, France, China, Spain, Italy, Germany, Romania, Denmark, Colombia and Indonesia.

Reception

From 2004 to 2006, USANA was named on Forbes "200 Best Small Companies" list. In 2007, a Forbes article quoted industry experts and government officials who had raised questions about the cost of USANA's supplements and its business practices. Radio-Canada later aired an investigative report that examined the company's products, pricing and "misleading income claims" made to potential associates concerning revenue. It included hidden-camera footage of recruitment and other sessions, which found one group of associates appeared to violate the company's policies and distributor agreements. This contrasted with the Canadian legal requirements for multi-level marketing companies to provide clear, frequent and complete information about the revenue of the typical participant. In addition, the same group of associates were filmed making recommendations for using USANA products to treat illnesses including leukemia.

John Cloud, senior writer for Time Magazine, evaluated nutritional supplements in which he took a regimen of USANA pills, protein bars, powder drinks and psyllium fiber as recommended by the company's online evaluation. Cloud took a blood test before starting the products to measure levels of calcium, protein, sodium, cholesterol, glucose, and other substances, and was then tested again five months after starting the supplement regimen, which included 3,000 pills at a cost of $1,200. The follow-up test revealed a change in only two values; a 75% increase in vitamin D levels (attributed to the vitamin D3 supplement Cloud had been taking) and a 28 mg/dl increase in high-density lipoprotein, which could not be accounted for. Cloud also experienced a placebo response where that act of taking the supplements made him feel more vigorous despite no physiological reasons being present. This response also led to a 10-lb weight gain, as the belief that he was more vigorous led him to make poorer dietary decisions—a phenomenon referred to as the "licensing effect".

New Zealand government statistician for the Commerce Commission, Murray H. Smith, who served as an expert witness in every pyramid scheme case brought by the Commission preceding 10 years, opined in 2008 that very few USANA distributors are likely to become wealthy, and stated, "you can make a very strong argument that this could be a pyramid scheme." When asked by the National Business Review to review the firm's business structure and compensation plan, it was Smith's opinion, from a statistical not legal standpoint, that the firm demonstrated a number of characteristics commonly occurring in pyramid schemes including that most members recoup less than what they pay to participate; that those at the top of the structure are more likely to make more than those on the bottom of the structure; and that as the company grows it will become harder to recruit others. Smith also noted the company's significant turnover in distributors making it necessary to continually recruit.

출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗

Wikidata ↗

USNA 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위

가격
$13.59
시가총액
$251M
P/E (TTM)
23.6
EPS (TTM)
$0.58
매출 (TTM)
$925M
배당 수익률
ROE
2.0%
부채/자본
52주 범위
$13 – $32

USNA 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의

10년 성과 매출, 순이익, 마진 및 EPS 추세

매출 및 순이익 $925M
10-point trend, -8.0%
2016-12-31 2026-01-03
EPS $0.58
10-point trend, -85.5%
2016-12-31 2026-01-03
잉여현금흐름 $9M
10-point trend, -91.8%
2016-12-31 2026-01-03
마진 1.2%
10-point trend, -4.6%
2016-12-31 2026-01-03

가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?

지표
5년 추세
USNA
동종업계 중앙값
P/E (TTM)
5-point trend, +89.8%
23.6
15.6
P/S (TTM)
5-point trend, -76.8%
0.3
0.6
P/B
5-point trend, -86.6%
0.5
2.6
Price / FCF (주가 / FCF)
5-point trend, +130.4%
29.4

수익성 총, 영업 및 순이익률; ROE, ROA, ROIC

지표
5년 추세
USNA
동종업계 중앙값
Gross Margin (매출 총이익률)
5-point trend, -4.1%
78.3%
69.1%
Operating Margin (영업이익률)
5-point trend, -71.8%
4.0%
Net Profit Margin (순이익률)
5-point trend, -88.2%
1.2%
3.9%
ROA
5-point trend, -92.5%
1.4%
5.0%
ROE
5-point trend, -93.1%
2.0%
9.6%
ROIC
5-point trend, -93.4%
1.9%

재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성

지표
5년 추세
USNA
동종업계 중앙값
Current Ratio (유동비율)
5-point trend, -1.2%
2.2
2.5
Quick Ratio (당좌 비율)
5-point trend, -17.4%
1.2

성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR

지표
5년 추세
USNA
동종업계 중앙값
Revenue YoY (매출 YoY)
5-point trend, -22.0%
8.3%
Revenue CAGR 3Y (매출 CAGR 3년)
5-point trend, -22.0%
-2.5%
Revenue CAGR 5Y (매출 CAGR 5년)
5-point trend, -22.0%
-4.0%
EPS YoY
5-point trend, -89.9%
-73.5%
Net Income YoY (순이익 YoY)
5-point trend, -90.8%
-74.4%

주당 지표 EPS, 주당 순자산, 주당 현금 흐름, 주당 배당금

지표
5년 추세
USNA
동종업계 중앙값
EPS (Diluted) (EPS (희석))
5-point trend, -89.9%
$0.58

자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율

지표
5년 추세
USNA
동종업계 중앙값

USNA 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력

매도 6 명의 애널리스트
  • 적극 매수 0 0.0%
  • 매수 0 0.0%
  • 보유 3 50.0%
  • 매도 1 16.7%
  • 적극 매도 2 33.3%

12개월 목표 주가

1 명의 애널리스트 · 2026-08-14
중앙값 목표 $25.00 +84.0%
평균 목표 $25.00 +84.0%

실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일

평균 서프라이즈
-0.10%
기간 EPS Actual EPS 예상 서프라이즈
2026년 6월 30일 $-0.07 $0.44 -0.51%
2026년 3월 31일 $0.61 $0.45 0.16%
2025년 12월 31일 $0.60 $0.42 0.18%
2025년 9월 30일 $-0.15 $0.48 -0.63%
2025년 6월 30일 $0.74 $0.55 0.19%
2025년 3월 31일 $0.73 $0.71 0.02%

동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업

티커 시가총액 P/E 매출 YoY 순이익률 ROE 매출 총이익률
USNA $355M 33.5 8.3% 1.2% 2.0% 78.3%
BRBR $4.39B 21.6 16.1% 9.3% -72.0% 33.3%
HNST $291M -18.4 -1.9% -4.2% -8.8% 33.3%
NATR $378M 20.4 5.7% 4.1% 12.0% 72.4%
NAGE $507M 31.8 29.9% 13.4% 24.7% 64.3%
NUS 3.0 -14.3% 10.8% 22.0% 69.5%
MED $117M -6.3 -36.0% -4.8% -9.0% 71.3%

전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름

손익계산서 18
USNA의 연간 손익계산서 데이터
지표 추세 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +17.1% $925M $855M $921M $999M $1.19B $1.13B $1.06B $1.19B $1.05B $1.01B $918M $790M
Cost of Revenue 12-point trend, +42.7% $201M $161M $177M $194M $218M $209M $188M $201M $179M $180M $160M $141M
Gross Profit 12-point trend, +11.5% $724M $693M $744M $805M $969M $926M $873M $989M $868M $826M $759M $650M
R&D Expense 12-point trend, +108.5% $11M $12M $11M $12M $11M $11M $10M $10M $9M $9M $6M $5M
SG&A Expense 12-point trend, +82.8% $337M $263M $257M $262M $279M $261M $268M $275M $265M $234M $209M $185M
Operating Expenses 12-point trend, +28.7% $687M $627M $651M $697M $798M $749M $727M $800M $735M $687M $617M $534M
Operating Income 12-point trend, -67.8% $37M $66M $93M $108M $170M $176M $146M $188M $133M $139M $142M $116M
Interest Expense 10-point trend, +103.1% · · $262.0K $192.0K $57.0K $507.0K $66.0K $36.0K $46.0K $444.0K $15.0K $129.0K
Interest Income 12-point trend, +383.0% $2M $11M $10M $4M $3M $3M $5M $4M $2M $1M $1M $500.0K
Other Non-op 12-point trend, +407.6% $3M $-1M $7.0K $-3M $-2M $-571.0K $-335.0K $-1M $-3.0K $-1M $-174.0K $-820.0K
Pretax Income 12-point trend, -64.1% $42M $76M $102M $109M $171M $178M $150M $192M $135M $139M $143M $116M
Income Tax 12-point trend, -23.0% $30M $34M $39M $39M $54M $53M $50M $65M $72M $39M $48M $39M
Net Income 12-point trend, -86.0% $11M $42M $64M $69M $117M $125M $101M $126M $63M $100M $95M $77M
EPS (Basic) 12-point trend, -80.0% $0.58 $2.20 $3.31 $3.60 $5.78 $5.89 $4.44 $5.24 $2.57 $4.14 $3.72 $2.90
EPS (Diluted) 12-point trend, -79.3% $0.58 $2.19 $3.30 $3.59 $5.73 $5.86 $4.41 $5.12 $2.53 $3.99 $3.59 $2.80
Shares (Basic) 12-point trend, -29.9% 18,535,000 19,103,000 19,250,000 19,254,000 20,146,000 21,156,000 22,644,000 24,105,000 24,349,000 24,185,000 25,460,000 26,443,000
Shares (Diluted) 12-point trend, -32.2% 18,574,000 19,162,000 19,345,000 19,310,000 20,343,000 21,256,000 22,818,000 24,642,000 24,708,000 25,047,000 26,355,000 27,377,000
EBITDA 12-point trend, -44.0% $70M $81M $106M $121M $183M $190M $161M $205M $149M $152M $152M $125M
대차대조표 26
USNA의 연간 대차대조표 데이터
지표 추세 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +42.5% $158M $182M $330M $288M $240M $312M $235M $214M $247M $176M $143M $111M
Receivables $4M · · · · · · · · · · ·
Inventory 12-point trend, +126.8% $103M $70M $61M $67M $98M $90M $69M $82M $63M $65M $66M $45M
Prepaid Expense 12-point trend, -33.1% $23M $28M $26M $29M $27M $23M $26M $33M $30M $37M $35M $35M
Other Current Assets 12-point trend, -13.7% $5M $5M $6M $7M $4M $5M $5M $7M $5M $6M $5M $6M
Current Assets 12-point trend, +51.1% $288M $279M $418M $384M $365M $425M $329M $392M $340M $278M $244M $191M
PP&E (Net) 12-point trend, +32.6% $94M $95M $100M $98M $102M $100M $95M $92M $103M $101M $88M $71M
PP&E (Gross) 10-point trend, +86.4% · · $212M $210M $211M $199M $181M $178M $177M $164M $120M $114M
Accum. Depreciation 12-point trend, +109.1% $135M $130M $129M $125M $122M $116M $105M $96M $86M $76M $71M $64M
Goodwill 12-point trend, +669.0% $138M $144M $17M $17M $18M $17M $17M $17M $17M $17M $17M $18M
Intangibles 12-point trend, +225.1% $133M $152M $30M $32M $30M $31M $30M $32M $35M $34M $38M $41M
Other Non-current Assets 12-point trend, +161.1% $62M $59M $55M $55M $58M $62M $43M $18M $21M $22M $25M $24M
Total Assets 12-point trend, +111.9% $743M $748M $633M $597M $578M $641M $517M $554M $519M $471M $423M $351M
Accounts Payable 12-point trend, +121.9% $17M $12M $10M $11M $14M $18M $13M $10M $12M $9M $10M $8M
Accrued Liabilities 3-point trend, -2.6% $10M $14M $10M · · · · · · · · ·
Current Liabilities 12-point trend, +18.3% $129M $140M $119M $144M $161M $168M $136M $149M $141M $138M $131M $109M
Capital Leases 6-point trend, -28.8% $12M $10M $5M $8M $10M · $17M · · · · ·
Deferred Tax 12-point trend, -53.9% $5M $4M $5M $4M $7M $12M $10M $13M $14M $5M $10M $11M
Other Non-current Liabilities 12-point trend, +1981.3% $23M $18M $12M $14M $14M $19M $19M $1M $1M $1M $1M $1M
Total Liabilities 3-point trend, +15.6% $157M $162M $136M · · · · · · · · ·
Common Stock 12-point trend, +38.5% $18.0K $19.0K $19.0K $19.0K $19.0K $21.0K $22.0K $24.0K $24.0K $24.0K $25.0K $13.0K
Retained Earnings 12-point trend, +179.9% $466M $479M $445M $392M $345M $383M $306M $330M $288M $265M $215M $166M
AOCI 12-point trend, -858.8% $-16M $-23M $-14M $-13M $458.0K $-4M $-14M $-10M $-1M $-12M $-4M $2M
Stockholders' Equity 12-point trend, +131.6% $533M $532M $497M $434M $395M $442M $352M $391M $363M $325M $281M $230M
Liabilities + Equity 12-point trend, +111.9% $743M $748M $633M $597M $578M $641M $517M $554M $519M $471M $423M $351M
Shares Outstanding 12-point trend, -27.6% 18,281,000 19,064,000 19,130,000 19,206,000 19,393,000 21,038,000 21,655,000 23,567,000 24,024,000 24,485,000 24,976,000 25,266,000
현금 흐름 16
USNA의 연간 현금 흐름 데이터
지표 추세 202520242023202220212020201920182017201620152014
D&A 12-point trend, +269.6% $33M $15M $13M $13M $13M $14M $15M $17M $16M $13M $10M $9M
Stock-based Comp 12-point trend, +41.0% $14M $15M $15M $13M $14M $14M $16M $15M $15M $17M $11M $10M
Deferred Tax 12-point trend, -586.8% $-7M $-7M $-3M $-7M $-3M $-2M $-4M $607.0K $19M $-4M $-3M $-1M
Amort. of Intangibles 12-point trend, +4382.1% $19M $2M $2M $2M $1M $1M $1M $2M $1M $2M $900.0K $431.0K
Restructuring 3-point trend, +6463000.00 $6M $0 $0 · · · · · · · · ·
Other Non-cash 12-point trend, -352.1% $-28M $-3M $-18M $15M $-20M $10M $-442.0K $-7M $10M $11M $-2M $11M
Operating Cash Flow 12-point trend, -78.8% $22M $61M $71M $104M $121M $160M $127M $152M $124M $137M $111M $105M
CapEx 12-point trend, -32.3% $14M $10M $14M $10M $13M $15M $17M $11M $13M $33M $24M $20M
Investing Cash Flow 12-point trend, +37.8% $-10M $-213M $-12M $-12M $-14M $-34M $47M $-69M $-13M $-32M $-25M $-16M
Stock Repurchased 12-point trend, -80.2% $28M $9M $12M $25M $178M $57M $150M $105M $50M $65M $61M $139M
Net Stock Activity 12-point trend, +80.2% $-28M $-9M $-12M $-25M $-178M $-57M $-150M $-105M $-50M $-65M $-61M $-139M
Financing Cash Flow 12-point trend, +64.1% $-41M $10M $-14M $-30M $-181M $-59M $-152M $-105M $-50M $-65M $-49M $-113M
Net Change in Cash 12-point trend, +11.2% $-23M $-149M $42M $48M $-72M $78M $20M $-33M $72M $32M $32M $-26M
Taxes Paid 3-point trend, -12.2% $37M $40M $42M · · · · · · · · ·
Free Cash Flow 12-point trend, -89.9% $9M $51M $56M $94M $108M $145M $110M $141M $111M $104M $88M $85M
Levered FCF 10-point trend, -33.9% · · $56M $93M $108M $145M $110M $141M $111M $104M $88M $85M
수익성 8
USNA의 연간 수익성 데이터
지표 추세 202520242023202220212020201920182017201620152014
Gross Margin 12-point trend, -4.7% 78.3% 81.1% 80.8% 80.6% 81.6% 81.6% 82.3% 83.1% 82.9% 82.1% 82.6% 82.2%
Operating Margin 12-point trend, -72.4% 4.0% 7.8% 10.1% 10.8% 14.3% 15.6% 13.8% 15.8% 12.7% 13.8% 15.4% 14.7%
Net Margin 12-point trend, -88.0% 1.2% 4.9% 6.9% 6.9% 9.8% 11.0% 9.5% 10.6% 6.0% 9.9% 10.3% 9.7%
Pretax Margin 12-point trend, -69.3% 4.5% 8.9% 11.1% 10.9% 14.4% 15.7% 14.2% 16.1% 12.9% 13.8% 15.5% 14.6%
EBITDA Margin 12-point trend, -52.2% 7.6% 9.5% 11.5% 12.1% 15.4% 16.8% 15.2% 17.2% 14.2% 15.1% 16.5% 15.8%
ROA 12-point trend, -93.2% 1.4% 6.1% 10.4% 11.8% 19.1% 21.5% 18.8% 23.5% 12.6% 22.4% 24.5% 21.3%
ROE 12-point trend, -93.5% 2.0% 7.9% 13.2% 16.4% 29.3% 30.0% 30.2% 30.5% 17.2% 33.0% 37.0% 31.2%
ROIC 12-point trend, -94.2% 1.9% 6.9% 11.7% 15.8% 29.4% 28.0% 27.8% 31.7% 16.9% 30.8% 33.5% 33.4%
유동성 및 지급능력 3
USNA의 연간 유동성 및 지급능력 데이터
지표 추세 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, +27.7% 2.2 2.0 3.5 2.7 2.3 2.5 2.4 2.6 2.4 2.0 1.9 1.8
Quick Ratio 12-point trend, +20.5% 1.2 1.3 2.8 2.0 1.5 1.9 1.7 1.4 1.8 1.3 1.1 1.0
Interest Coverage 10-point trend, -60.5% · · 355.2 560.5 2985.8 348.1 2215.0 5232.0 2880.5 312.2 9444.1 900.0
효율성 2
USNA의 연간 효율성 데이터
지표 추세 202520242023202220212020201920182017201620152014
Asset Turnover 12-point trend, -43.6% 1.2 1.2 1.5 1.7 1.9 2.0 2.0 2.2 2.1 2.3 2.4 2.2
Inventory Turnover 12-point trend, -23.4% 2.3 2.5 2.7 2.3 2.3 2.2 2.5 2.8 2.8 2.8 2.9 3.0
주당 5
USNA의 연간 주당 데이터
지표 추세 202520242023202220212020201920182017201620152014
Book Value / Share 12-point trend, +60.1% $29.16 $27.91 $25.99 $22.62 $20.37 $20.99 $16.24 $16.60 $15.12 $13.29 $22.49 $18.22
Revenue / Share 12-point trend, -13.7% $49.81 $44.59 $47.61 $51.71 $58.32 $53.38 $46.49 $48.26 $42.39 $40.17 $69.70 $57.74
Cash Flow / Share 12-point trend, -84.3% $1.20 $3.18 $3.65 $5.38 $5.96 $7.55 $5.55 $6.17 $5.01 $5.47 $8.46 $7.68
Cash / Share 12-point trend, -1.5% $8.66 $9.53 $17.27 $15.02 $12.37 $14.83 $10.84 $9.09 $10.29 $7.18 $11.47 $8.80
EPS (TTM) 12-point trend, -79.3% $0.58 $2.19 $3.30 $3.59 $5.73 $5.86 $4.41 $5.12 $2.53 $3.99 $3.59 $2.80
성장률 9
USNA의 연간 성장률 데이터
지표 추세 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, +81.2% 8.3% -7.2% -7.8% -15.8% 4.6% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +62.6% -2.5% -10.4% -6.7% · · · · · · · · ·
Revenue CAGR 5Y -4.0% · · · · · · · · · · ·
EPS YoY 5-point trend, -3211.7% -73.5% -33.6% -8.1% -37.4% -2.2% · · · · · · ·
EPS CAGR 3Y 3-point trend, -161.4% -45.5% -27.4% -17.4% · · · · · · · · ·
EPS CAGR 5Y -37.0% · · · · · · · · · · ·
Net Income YoY 5-point trend, -1037.6% -74.4% -34.1% -8.0% -40.5% -6.5% · · · · · · ·
Net Income CAGR 3Y 3-point trend, -131.1% -46.3% -28.8% -20.0% · · · · · · · · ·
Net Income CAGR 5Y -38.7% · · · · · · · · · · ·
가치 평가 (TTM) 10
USNA의 연간 가치 평가 (TTM) 데이터
지표 추세 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +17.1% $925M $855M $921M $999M $1.19B $1.13B $1.06B $1.19B $1.05B $1.01B $918M $790M
Net Income TTM 12-point trend, -86.0% $11M $42M $64M $69M $117M $125M $101M $126M $63M $100M $95M $77M
Market Cap 12-point trend, -45.0% $355M $680M $1.03B $1.02B $1.96B $1.62B $1.73B $2.71B $1.78B $1.50B $798M $646M
P/E 12-point trend, +83.5% 33.5 16.3 16.2 14.8 17.7 13.2 18.1 22.5 29.3 15.3 17.8 18.3
P/S 12-point trend, -53.0% 0.4 0.8 1.1 1.0 1.7 1.4 1.6 2.3 1.7 1.5 0.9 0.8
P/B 12-point trend, -76.3% 0.7 1.3 2.1 2.4 5.0 3.7 4.9 6.9 4.9 4.6 2.8 2.8
P / Tangible Book 6-point trend, -67.1% 1.4 2.9 2.3 2.7 5.7 4.1 · · · · · ·
P / Cash Flow 12-point trend, +158.9% 15.9 11.2 14.5 9.8 16.2 10.1 13.7 17.8 14.4 10.9 7.2 6.1
P / FCF 12-point trend, +446.9% 41.7 13.4 18.3 10.9 18.1 11.2 15.7 19.3 16.1 14.4 9.1 7.6
Earnings Yield 12-point trend, -45.6% 3.0% 6.1% 6.2% 6.8% 5.7% 7.6% 5.5% 4.5% 3.4% 6.5% 5.6% 5.5%

재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년

손익계산서
2026-01-032024-12-282023-12-302022-12-312022-01-01
매출 $925M$855M$921M$999M$1.19B
매출 총이익률 % 78.3%81.1%80.8%80.6%81.6%
영업이익률 % 4.0%7.8%10.1%10.8%14.3%
순이익 $11M$42M$64M$69M$117M
희석 EPS $0.58$2.19$3.30$3.59$5.73
대차대조표
2026-01-032024-12-282023-12-302022-12-312022-01-01
유동비율 2.22.03.52.72.3
당좌 비율 1.21.32.82.01.5
현금 흐름
2026-01-032024-12-282023-12-302022-12-312022-01-01
잉여현금흐름 $9M$51M$56M$94M$108M

나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목

📊

중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.

선택 항목이 저장되어 모든 티커에서 유지됩니다.

기관 투자자 (13F) 152개의 제출자 · $176.6M 전체 · 기준일 2026년 6월 30일

분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.

기관 활동 — Q2 2026 대 이전 분기
신규 포지션 청산 포지션 증가함 감소 순주식 변동
30 (+4 이전 분기 대비) 16 (+6 이전 분기 대비) 48 (+5 이전 분기 대비) 34 (-7 이전 분기 대비) +1.1M

Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.

기관 가치 주식 % 추적된 13F 중 유형
PZENA INVESTMENT MANAGEMENT LLC $25,739,282 1,205,587 14.58% 주식
RENAISSANCE TECHNOLOGIES LLC $20,464,402 958,520 11.59% 주식
Nantahala Capital Management, LLC $17,295,080 810,074 9.80% 주식
DIMENSIONAL FUND ADVISORS LP $16,958,134 794,292 9.61% 주식
VANGUARD CAPITAL MANAGEMENT LLC $10,405,350 487,370 5.89% 주식
VANGUARD PORTFOLIO MANAGEMENT LLC $7,758,099 363,377 4.39% 주식
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $5,811,641 272,208 3.29% 주식
STATE STREET CORP $5,577,474 261,240 3.16% 주식
GEODE CAPITAL MANAGEMENT, LLC $5,175,448 242,342 2.93% 주식
AMERICAN CENTURY COMPANIES INC $3,999,880 187,348 2.27% 주식
JACOBS LEVY EQUITY MANAGEMENT, INC $3,855,105 180,567 2.18% 주식
TWO SIGMA INVESTMENTS, LP $3,533,724 165,514 2.00% 주식
D. E. Shaw & Co., Inc. $3,348,427 156,835 1.90% 주식
Allianz Asset Management GmbH $3,040,219 142,399 1.72% 주식
BRIDGEWAY CAPITAL MANAGEMENT, LLC $2,949,567 138,153 1.67% 주식
ALGERT GLOBAL LLC $2,813,033 131,758 1.59% 주식
UBS Group AG $2,474,166 115,886 1.40% 주식
BlackRock, Inc. $2,353,005 110,211 1.33% 주식
LAZARD ASSET MANAGEMENT LLC $2,077,590 97,311 1.18% 주식
VANGUARD FIDUCIARY TRUST CO $1,549,540 72,578 0.88% 주식
Vanguard Global Advisers, LLC $1,514,569 70,940 0.86% 주식
Empowered Funds, LLC $1,499,902 70,253 0.85% 주식
AMERIPRISE FINANCIAL INC $1,443,624 67,617 0.82% 주식
TWO SIGMA ADVISERS, LP $1,289,691 65,700 0.73% 주식
GOLDMAN SACHS GROUP INC $1,121,921 52,549 0.64% 주식
Quantinno Capital Management LP $1,072,261 50,223 0.61% 주식
BANK OF AMERICA CORP /DE/ $967,539 45,318 0.55% 주식
ROYCE & ASSOCIATES LP $884,039 41,407 0.50% 주식
DEUTSCHE BANK AG\ $821,975 38,500 0.47% 주식
Assenagon Asset Management S.A. $815,848 38,213 0.46% 주식
BARCLAYS PLC $769,220 36,029 0.44% 주식
STRS OHIO $723,765 33,900 0.41% 주식
Skopos Labs, Inc. $673,696 38,563 0.38% 주식
HSBC HOLDINGS PLC $672,758 31,960 0.38% 주식
Bank of New York Mellon Corp $668,447 31,309 0.38% 주식
XTX Topco Ltd $625,320 29,289 0.35% 주식
MILLENNIUM MANAGEMENT LLC $570,728 26,732 0.32% 주식
CITADEL ADVISORS LLC $569,639 26,681 0.32% 주식
Verdad Advisers, LP $556,552 26,068 0.32% 주식
Sanctuary Advisors, LLC $497,113 23,284 0.28% 주식
Man Group plc $489,854 22,944 0.28% 주식
State of Tennessee, Department of Treasury $461,160 21,600 0.26% 주식
Point72 Asset Management, L.P. $397,238 18,606 0.22% 주식
Unison Advisors LLC $384,300 18,000 0.22% 주식
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO $384,215 17,996 0.22% 주식
Numerai GP LLC $382,080 17,896 0.22% 주식
KLP KAPITALFORVALTNING AS $375,760 17,600 0.21% 주식
Connor, Clark & Lunn Investment Management Ltd. $366,836 17,182 0.21% 주식
ALLIANCEBERNSTEIN L.P. $357,611 20,470 0.20% 주식
CITADEL ADVISORS LLC $356,545 16,700 0.20% 풋 옵션
Park Capital Management, LLC / WI $345,144 16,166 0.20% 주식
Engineers Gate Manager LP $337,672 15,816 0.19% 주식
SEGALL BRYANT & HAMILL, LLC $318,414 14,914 0.18% 주식
RHUMBLINE ADVISERS $309,778 14,510 0.18% 주식
Vanguard Personalized Indexing Management, LLC $309,724 14,507 0.18% 주식
FIRST TRUST ADVISORS LP $308,998 14,473 0.18% 주식
Toroso Investments, LLC $304,756 15,525 0.17% 주식
EXCHANGE TRADED CONCEPTS, LLC $300,992 14,098 0.17% 주식
IEQ CAPITAL, LLC $300,245 14,063 0.17% 주식
Y-Intercept (Hong Kong) Ltd $298,366 13,975 0.17% 주식
Focus Partners Wealth $292,794 13,714 0.17% 주식
CITADEL ADVISORS LLC $273,280 12,800 0.15% 콜 옵션
BNP PARIBAS FINANCIAL MARKETS $263,160 12,326 0.15% 주식
MERCER GLOBAL ADVISORS INC /ADV $243,881 11,423 0.14% 주식
State of Wyoming $242,237 11,346 0.14% 주식
ANCHYRA PARTNERS LLC $230,238 10,784 0.13% 주식
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $229,982 10,772 0.13% 주식
OCCUDO QUANTITATIVE STRATEGIES LP $226,652 10,616 0.13% 주식
Mariner, LLC $219,915 10,302 0.12% 주식
DGS Capital Management, LLC $207,876 11,899 0.12% 주식
Cerity Partners LLC $141,913 6,647 0.08% 주식
Magnetar Financial LLC $138,540 6,489 0.08% 주식
MetLife Investment Management, LLC $124,236 5,819 0.07% 주식
Russell Investments Group, Ltd. $123,637 5,791 0.07% 주식
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $109,931 5,149 0.06% 주식
Creative Planning $107,156 5,019 0.06% 주식
FMR LLC $105,661 4,949 0.06% 주식
SIGNATUREFD, LLC $101,391 4,749 0.06% 주식
CWM, LLC $97,413 5,576 0.06% 주식
VANGUARD GROUP INC $96,226 4,902 0.05% 주식
Invesco Ltd. $95,072 4,453 0.05% 주식
NEW YORK STATE COMMON RETIREMENT FUND $81,045 3,796 0.05% 주식
Police & Firemen's Retirement System of New Jersey $73,935 3,463 0.04% 주식
Parallel Advisors, LLC $70,818 3,317 0.04% 주식
Farther Finance Advisors, LLC $41,873 1,964 0.02% 주식
Arax Advisory Partners $40,588 1,901 0.02% 주식
NATIONAL BANK OF CANADA /FI/ $40,499 1,896 0.02% 주식
AlphaQuest LLC $38,259 1,949 0.02% 주식
NORTHERN TRUST CORP $37,533 1,758 0.02% 주식
OSAIC HOLDINGS, INC. $34,383 1,611 0.02% 주식
LOM Asset Management Ltd $34,160 1,600 0.02% 주식
Versant Capital Management, Inc $33,904 1,588 0.02% 주식
MORGAN STANLEY $31,363 1,469 0.02% 주식
Ameritas Investment Partners, Inc. $23,933 1,121 0.01% 주식
Tower Research Capital LLC (TRC) $22,909 1,073 0.01% 주식
Legal & General Group Plc $20,966 982 0.01% 주식
Integrated Wealth Concepts LLC $18,833 882 0.01% 주식
CITIGROUP INC $17,635 826 0.01% 주식
Global Retirement Partners, LLC $14,433 676 0.01% 주식
Allworth Financial LP $14,027 657 0.01% 주식

회사 내부자 38 명의 내부자 · 20 임원 · 13 이사

내부자 역할 마지막 활동 보유 주식 수 매수 12개월 매도 12개월 순매수/매도 12개월
Jim Brown CEO & PRESIDENT 2025년 7월 24일 M 16,934 0 0 $0
Doug G Iiekking CHIEF FINANCIAL OFFICER 2026년 5월 27일 S 0 0 1 $-100,500
Jeffrey Yates Chief Financial Officer 2010년 10월 28일 M 0 0 0 $0
Deborah Woo President of Asia 2016년 9월 8일 M 1,479 0 0 $0
Fred W Cooper President and COO 2010년 10월 28일 M 0 0 0 $0
Walter Noot CHIEF OPERATING OFFICER 2026년 2월 19일 A 0 0 0 $0
Roy Truett Chief Operating Officer 2012년 7월 27일 M 0 0 0 $0
Kathryn Michelle Armstrong CHIEF SCIENTIFIC OFFICER 2026년 7월 25일 M 3,471 0 0 $0
Peter Benedict CHIEF INFORMATION OFFICER 2026년 7월 25일 M 422 0 0 $0
Brent Neidig CHIEF COMMERCIAL OFFICER 2026년 6월 16일 S 0 0 3 $-147,749
Paul A. Jones CHIEF PEOPLE OFFICER 2026년 6월 8일 S 0 0 1 $-102,878
David Mulham Mulham CHIEF SALES OFFICER 2025년 7월 30일 S 9,260 0 0 $0
Joshua Foukas CHIEF LEGAL OFFICER 2025년 3월 12일 S 0 0 0 $0
Daniel A. Macuga CHIEF COMMUNICATIONS OFFICER 2024년 5월 2일 S 0 0 0 $0
Robert A Sinnott CHIEF SCIENTIFIC OFFICER 2024년 3월 5일 S 0 0 0 $0
James Bramble Chief Legal Officer and Sec 2018년 2월 5일 A 2,076 0 0 $0
Dave Wentz Co-C.E.O. 2016년 8월 16일 M 384,883 0 0 $0
Rick Stambaugh Chief Information Officer 2015년 12월 17일 M 0 0 0 $0
Mark H Wilson E.V.P. of Sales 2010년 10월 28일 M 5,000 0 0 $0
Bradford Richardson E.V.P. of Asia Pacific 2008년 2월 25일 S 0 0 0 $0
Xia Ding 이사 2026년 7월 23일 M 8,278 0 0 $0
John Turman Fleming 이사 2026년 7월 23일 M 5,862 0 1 $-43,928
Peggie Pelosi 이사 2026년 7월 23일 M 6,061 0 0 $0
Scott J Nixon 이사 2026년 7월 23일 M 11,445 0 0 $0
Frederic J Winssinger 이사 2026년 7월 23일 M 9,733 0 0 $0
Timothy E Wood 이사 2026년 7월 23일 M 11,837 0 0 $0
Gilbert A Fuller 이사 2026년 7월 23일 M 1,632 0 3 $-60,414
Robert Auciaux 이사 2022년 2월 9일 M 436 0 0 $0
Feng Peng 이사 2021년 4월 28일 M 755 0 0 $0
Myron W. Wentz 이사 2019년 2월 4일 S 9,865,614 0 0 $0
Jerry G Mcclain 이사 2016년 3월 4일 M 0 0 0 $0
Ronald S Poelman 이사 2016년 2월 8일 A 0 0 0 $0
Denis E Waitley 이사 2006년 11월 3일 M 0 0 0 $0
Gull Global Limited 10% 소유주 2019년 2월 4일 S 9,865,614 0 0 $0
GULL HOLDINGS LTD 10% 소유주 2015년 4월 1일 J 6,491,110 0 0 $0
Kevin Guest 2026년 2월 27일 M 45,381 0 0 $0
Donald R. Williams 2017년 5월 1일 A 0 0 $0
Doug Braun 2015년 12월 16일 M 0 0 0 $0

SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당

행동주의자 및 5% 이상 소유자 3 보유

SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.

제출자 제출됨 지분 상태 목적 제출
Gull Global Limited, Myron W. Wentz ×11 제출 서류 2026년 3월 30일 40.10% 수정본 M&A / 매각 SEC
Gull Holdings, Ltd., Myron W. Wentz, David A. Wentz, Jacquelyn R. Wentz, Bryan Wentz, Annette Wentz, Paul & Jane Meyer Family Foundation, Paul James Meyer, Alice Jane Meyer, Centre Island Properties, Ltd., Waco Boys Club Foundation, Inc., L-K Marketing Group, LLC, Beagle Irrevocable Asset Trust 2008년 5월 23일 최초 제출 SEC
Paul & Jane Meyer Family Foundation 2008년 5월 20일 최초 제출 수동적 투자 SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF 보유 현황 38 ETF 보유

가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.

펀드 비중 단위 기준일 출처
DEEP · ETF Series Solutions 0.95% 13,646 NS 2026년 5월 31일 N-PORT
AFSM · First Trust Exchange-Traded Fund VI… 0.25% 13,206 NS 2026년 5월 31일 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0.11% 45,046 SH 2026년 8월 8일 일간
EBIT · Harbor ETF Trust 0.06% 387 NS 2026년 4월 30일 N-PORT
IWC · iShares Trust 0.04% 38,121 SH 2026년 8월 8일 일간
FNDA · SCHWAB STRATEGIC TRUST 0.03% 169,505 NS 2026년 5월 31일 N-PORT
VDC · VANGUARD WORLD FUND 0.03% 128,565 SH 2026년 8월 8일 일간
GSSC · Goldman Sachs ETF Trust 0.03% 15,259 NS 2026년 5월 31일 N-PORT
DFSV · Dimensional ETF Trust 0.02% 87,994 NS 2026년 4월 30일 N-PORT
VTWV · VANGUARD SCOTTSDALE FUNDS 0.02% 9,639 SH 2026년 8월 8일 일간
DFAT · Dimensional ETF Trust 0.01% 97,080 NS 2026년 4월 30일 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0.01% 24,189 SH 2026년 8월 8일 일간
AVSC · AMERICAN CENTURY ETF TRUST 0.01% 18,642 NS 2026년 5월 31일 N-PORT
AVUV · AMERICAN CENTURY ETF TRUST 0.01% 159,569 NS 2026년 5월 31일 N-PORT
IWN · iShares Trust 0.01% 101,080 SH 2026년 8월 8일 일간
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 64,278 SH 2026년 8월 8일 일간
DFAS · Dimensional ETF Trust 0.01% 60,807 NS 2026년 4월 30일 N-PORT
SMLF · iShares Trust 0.01% 22,748 SH 2026년 8월 8일 일간
OMFS · Invesco Exchange-Traded Self-Indexe… 0.01% 1,195 SH 2026년 8월 8일 일간
RSSL · Global X Funds 0.01% 4,685 NS 2026년 4월 30일 N-PORT
IWM · iShares Trust 0.01% 283,211 SH 2026년 8월 8일 일간
ITWO · ProShares Trust 0.01% 508 NS 2026년 5월 31일 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0.00% 51,773 NS 2026년 5월 31일 N-PORT
FNDB · SCHWAB STRATEGIC TRUST 0.00% 2,158 NS 2026년 5월 31일 N-PORT
UWM · ProShares Trust 0.00% 397 NS 2026년 5월 31일 N-PORT
URTY · ProShares Trust 0.00% 406 NS 2026년 5월 31일 N-PORT
AVSU · AMERICAN CENTURY ETF TRUST 0.00% 247 NS 2026년 5월 31일 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0.00% 388 NS 2026년 5월 31일 N-PORT
HDG · ProShares Trust 0.00% 10 NS 2026년 5월 31일 N-PORT
AVUS · AMERICAN CENTURY ETF TRUST 0.00% 5,468 NS 2026년 5월 31일 N-PORT
DFAC · Dimensional ETF Trust 0.00% 19,278 NS 2026년 4월 30일 N-PORT
ITOT · iShares Trust 0.00% 22,758 SH 2026년 8월 8일 일간
IWV · iShares Trust 0.00% 3,680 SH 2026년 8월 8일 일간
SCHB · SCHWAB STRATEGIC TRUST 0.00% 6,500 NS 2026년 5월 31일 N-PORT
DFUS · Dimensional ETF Trust 0.00% 1,784 NS 2026년 4월 30일 N-PORT
VXF · VANGUARD INDEX FUNDS 0.00% 124,681 SH 2026년 8월 8일 일간
VTI · VANGUARD INDEX FUNDS 0.00% 350,035 SH 2026년 8월 8일 일간
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 790 SH 2026년 8월 8일 일간